AL
Insider
ADAR1 Capital Management, LLC
10% ownerADAR1 Capital Management, LLC (10% owner) filed 10 Form 4 reports as a reporting entity in the trailing twelve months (10 purchases, 0 sales), most often in Rallybio Corporation (RLYB). Across 9 priced purchase filings, the average 21-session return was +5.2% from execution and +12.8% from disclosure (delay-adjusted; derived). The largest single filing was $2.1M of RLYB (152,005 sh across 2 lots, as filed), executed May 4. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+5.2%
avg across 9 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+12.8%
same 9 filings, from disclosure
Filings, ttm
10
10 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$12.5M
shares × price, as filed
Last traded
Oct 21
Filed Oct 21
Median ADV $7.2M across their filed names
Impact on $10,000 · 12M
$17,680 (+76.8%)
S&P 500 $10,907 (+9.1%) · 67.7 pts ahead
ADAR1 Capital Management, LLC
S&P 500
Derived: compounded across filings from disclosure dates · past 12 months
Open performance→Volume by month
Buys $12.5M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
10 filings
Sector per market data · by filing · past 12 months
Most traded names
RLYBRecent filings
TENXPURCHASE
Tenax Therapeutics, Inc.
View filing →
$1.5M922,849 sh across 3 lots
Exec Oct 19
Filed Oct 21 · 4:49 PM ET TENXPURCHASE Tenax Therapeutics, Inc. View filing → $1.6M
900,000 sh × $1.78
Exec Sep 3
Filed Sep 8 · 5:16 PM ET TENXPURCHASE Tenax Therapeutics, Inc. View filing → $1.4M
770,333 sh across 3 lots
Exec Aug 31
Filed Sep 2 · 5:52 PM ET TENXPURCHASE Tenax Therapeutics, Inc. View filing → $1.8M
1,025,867 sh across 3 lots
Exec Aug 20
Filed Aug 24 · 6:12 PM ET NXTCPURCHASE NextCure, Inc. View filing → $1.6M
317,850 sh across 7 lots
Exec Jul 30
Filed Aug 3 · 5:53 PM ET INMPURCHASE InMed Pharmaceuticals Inc. View filing → $722K
468,551 sh across 3 lots
Exec May 19
Filed May 21 · 5:08 PM ET RLYBPURCHASE Rallybio Corporation View filing → $140K
10,000 sh × $13.98
Exec May 19
Filed May 20 · 8:45 PM ET RLYBPURCHASE Rallybio Corporation View filing → $1.1M
75,178 sh × $14.00
Exec May 13
Filed May 15 · 8:49 PM ET More filings →